Telum Therapeutics Raises $18.0M

Verifee.ai

Verifee je rozšíření do prohlížeče, které hodnotí důvěryhodnost českých zpravodajských článků za účelem ochránit své uživatele před manipulacemi na internetu.

KnowTransfer

At KnowTransfer, we're passionate about nurturing the future of innovation! We bridge the gap between groundbreaking research and market success, empowering tech-based companies, universities, and research centers to thrive. From validating new technologies to securing funding and connecting talent, we're here to grow the innovation ecosystem. Discover how KnowTransfer accelerates impact! #KnowTransfer #InnovationEcosystem #TechCommercialization

VIOLET Pharmaceuticals

VIOLET Pharmaceuticals is a preclinical stage biopharma company developing a First-in-Class mRNA therapy against metastatic cancers. The company develops nanotherapies improving immunotherapies’ efficiency and approved indications (e.g. Immune Checkpoints Inhibitors (ICI)) by increasing the whole Antigen Presentation Machinery (APM) in tumor cells. Our mRNA technology is backed by Top-Notch science published in leading journals such as Nature Cell Biology and Nature Cancer, and has a strong IP position (3 patents). We achieved radical complete responses with our mRNA NanoTherapy in combination with ICI in several breast cancer tumors and metastasis models. Our mRNA specifically modulates the whole Antigen Presentation Machinery which determines immune detection (tumor visibility) and immunotherapy response. There are currently no specific APM-modulating therapies on the market, only competitors with indirect APM modulation. Therefore, our patented mRNA therapy emerges as a critical therapeutic partner to make tumor cells visible and vulnerable to immunotherapies. VIOLET Pharmaceuticals : Visibility to Immuno-Oncology & Lymphocyte Enhancing Therapies

Nexyra Advanced Research

Multi-omics intelligence for precision medicine. We accelerate biotech and precision medicine innovation through advanced bioinformatics, multi-omics intelligence and AI-powered asset evaluation. Nexyra helps biotech, pharma, investors and business development teams transform complex molecular, clinical and competitive evidence into decision-ready insights—supporting R&D optimization, therapeutic asset evaluation, biomarker discovery, target prioritization and me-too / me-better strategy with greater speed, rigor and confidence.

DefendSphere

DefendSphere is an AI-powered GRC (Governance, Risk and Compliance) platform that automates IT audits and simplifies compliance with key standards like EU AI Act, NIS2, GDPR, DORA, SOC 2, ISO/IEC 27001, and more. We help SMEs and enterprises proactively identify vulnerabilities, reduce risk exposure, and continuously secure their digital infrastructure, with minimal manual effort. From regulatory readiness to real-time visibility, DefendSphere makes modern cybersecurity scalable, efficient, and accessible.